Oncology Information Center
In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.
Oncology Information Center
The frequency of targetable alterations was roughly 22% in patients of African ancestry and those of European ancestry.
Heart Failure Information Center
Heart failure patients have significantly higher likelihood of developing depression within five years
AANP 2021
NP expert discusses the 5 principal components of survivorship care for patients with cancer.
Imaging
At a Glance Prostate cancer should be considered in any male patient older than 40 years of age with lower urinary tract symptoms (LUTS). Prostate cancer develops from the prostate, a gland that is part of the male reproductive system, located below the bladder, in front of the rectum, and embracing the urethra. In the…
Oncology
The USPSTF has updated its 2012 recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer.
Oncology
A lack of understanding of terminology, health care system distrust, and a lack of prostate cancer knowledge are among the barriers to genomic testing for prostate cancer and prostate cancer research participation among black men.
Men's Health Information Center
The USPSTF recommends that prostate cancer screenings should be an individual decision.
Men's Health Information Center
Interview study identifies men’s perception and concerns related to their prostate cancer journey.
Men's Health Information Center
For men with metastatic prostate cancer, aggressive therapy has no significant advantage over conservative androgen deprivation only treatments.
